OBJECTIVE: To test the hypothesis that obstructive sleep apnoea (OSA) is more common in pregnancies complicated by hypertensive disease and fetal growth restriction. STUDY DESIGN: An observational study comparing pregnant women with these two complications with normal pregnant women and non-pregnant women in two UK maternity hospitals. Each participant completed a sleep apnoea questionnaire and underwent nocturnal oxygen saturation monitoring. RESULTS: Using a strict definition of obstructive sleep apnoea confirmed by oxygen saturation monitoring only two mild cases were seen, 0/50 non-pregnant women, 1/69 of normal pregnant women, 0/48 women with various types of hypertensive disease, and 1/33 women carrying fetuses affected with fetal growth restriction. Even using less strict definitions and self-reported sleepiness scores there was no relation between sleep apnoea and either fetal growth restriction or hypertensive diseases. CONCLUSION: Obstructive sleep apnoea is at most a rare cause of either growth restriction or hypertensive disease in pregnancy.
OBJECTIVE: To test the hypothesis that obstructive sleep apnoea (OSA) is more common in pregnancies complicated by hypertensive disease and fetal growth restriction. STUDY DESIGN: An observational study comparing pregnant women with these two complications with normal pregnant women and non-pregnant women in two UK maternity hospitals. Each participant completed a sleep apnoea questionnaire and underwent nocturnal oxygen saturation monitoring. RESULTS: Using a strict definition of obstructive sleep apnoea confirmed by oxygen saturation monitoring only two mild cases were seen, 0/50 non-pregnant women, 1/69 of normal pregnant women, 0/48 women with various types of hypertensive disease, and 1/33 women carrying fetuses affected with fetal growth restriction. Even using less strict definitions and self-reported sleepiness scores there was no relation between sleep apnoea and either fetal growth restriction or hypertensive diseases. CONCLUSION:Obstructive sleep apnoea is at most a rare cause of either growth restriction or hypertensive disease in pregnancy.
Authors: John Reid; Regina Taylor-Gjevre; John Gjevre; Robert Skomro; Mark Fenton; Femi Olatunbosun; John R Gordon; David Cotton Journal: J Clin Sleep Med Date: 2013-04-15 Impact factor: 4.062
Authors: John Reid; Robert Skomro; David Cotton; Heather Ward; Femi Olatunbosun; John Gjevre; Christian Guilleminault Journal: Sleep Date: 2011-08-01 Impact factor: 5.849
Authors: Jordan P R McIntyre; Cayley M Ingham; B Lynne Hutchinson; John M D Thompson; Lesley M McCowan; Peter R Stone; Andrew G Veale; Robin Cronin; Alistair W Stewart; Kevin M Ellyett; Edwin A Mitchell Journal: BMC Pregnancy Childbirth Date: 2016-05-18 Impact factor: 3.007